The sale is small relative to ResMed's market cap and appears to be a routine exercise-and-sell transaction by an insider. No material signal for the stock. Monitor for any subsequent Form 4 filings to confirm whether the sale was executed.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Oct 8 $226.73entry
- T+1 · 6w ago +1.46%α +0.86% · $230.05
- T+5 · 5w ago +6.84%α +7.11% · $242.23
- T+20 · 12d ago +6.08%α +11.37% · $240.51
- T+27 · todayOpen
- T+60 · in 7w Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Michael J. Farrell, an officer and director of ResMed, filed a Form 144 notice of intent to sell 4,991 shares of common stock, with an estimated aggregate market value of approximately $1,129,637.70. The shares were acquired via stock option exercise on the same date as the filing, and the proposed sale is to be executed through Fidelity Brokerage Services LLC on the NYSE.
Key Facts
- Insider: Michael J. Farrell (Officer, Director)
- Shares to be sold: 4,991 shares of common stock
- Estimated value: ~$1,129,637.70
- Acquisition: Stock option exercise on 10/07/2026
- Broker: Fidelity Brokerage Services LLC
- Exchange: NYSE
- Filing date: 2026-10-07
Financial Impact
Sale of 4,991 shares valued at ~$1.13 million, representing a small fraction of the issuer's market cap (ResMed's market cap is ~$30B+).
Risk Factors
- Insider selling could be perceived negatively if it precedes a negative catalyst, though the small size limits concern.
- Form 144 is an intent to sell; the actual sale may not occur.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007310 |
| Document: 0001959173-26-007310-index.html | 0001959173-26-007310 |
| Document: 0001959173-26-007310.txt | 0001959173-26-007310 |
Track record
19 reports on RMD
4 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +28.97% at T+60 after the Jun 1, 2026 report. 6 of 6 went positive at some point.
Filters
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $234.11 Now $238.19 +1.74% settles Dec 9
- Oct 29, 202618d ago 8-K Bullish 6/10 No price data
- Oct 29, 202618d ago Press Release Bullish 6/10 Entry $229.94 Now $238.19 +3.59% settles Nov 30
- Oct 16, 20264w ago Institutional Cluster Bearish 4/10 Entry $238.88 to $238.19 Now $238.19 +0.29% ▲ +0.29% −3.17% vs SPY
- Oct 7, 20265w ago 144 Neutral 3/10 Viewing Entry $226.73 to $240.51 Now $238.19 +5.05% ▲ +6.08% +11.37% vs SPY
- Oct 1, 20266w ago DEFA14A Neutral 2/10 Entry $218.89 to $229.94 Now $238.19 +8.82% ▲ +5.05% +6.86% vs SPY
- Oct 1, 20266w ago DEF 14A Neutral 4/10 Entry $218.89 to $252.83 Now $238.19 +8.82% ▲ +15.51% +17.31% vs SPY
- Oct 1, 20266w ago Press Release Neutral 1/10 Entry $218.89 Now $238.19 +8.82% No price data
- Sep 10, 20269w ago Insider Cluster Neutral 4/10 Entry $219.58 to $226.73 Now $238.19 +8.48% ▲ +3.26% +1.13% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $224.84 to $219.95 Now $238.19 +5.94% ▼ −2.17% −1.12% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers